State Of Wyoming Arbutus Biopharma Corp Transaction History

State Of Wyoming

  • $587 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$2.23 - $3.1 $68,911 - $95,796
-30,902 Reduced 73.74%
11,005 $33,000
Q4 2022

Feb 14, 2023
BUY
$1.91 - $2.85 $17,333 - $25,863
9,075 Added 27.64%
41,907 $97,000
Q3 2022

Nov 14, 2022
BUY
$1.88 - $2.88 $61,724 - $94,556
32,832 New
32,832 $63,000

Others Institutions Holding ABUS

# of Institutions
130
Shares Held
82.2M
Call Options Held
4.82M
Put Options Held
546K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $489M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email